Biomarker discovery is essential to advancing precision medicine, yet researchers face common challenges: complex assays that generate massive datasets, imaging workflows that are difficult to scale, and connecting results into actionable insights remains a struggle. These barriers slow discovery, limit reproducibility, and make it harder to translate findings into clinical impact.
In this webinar, discover how Leica Microsystems and Molecular Devices, Life Sciences companies of Danaher, address these challenges through integrated, AI-powered solutions. Learn how advanced imaging and analytics platforms accelerate phenotypic screening, reveal spatial and morphological context, and help you move from data to discovery with greater speed, confidence, and translational relevance. Key takeaways:
Gain spatial insights and cellular context using Aivia AI Image Analysis Software from Leica Microsystems
Reduce the time and complexity of phenotypic screening with IN Carta Image Analysis Software from Molecular Devices